CeGaT Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 210

Employees

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 2

CeGaT General Information

Description

Provider of diagnostic biotechnology services intended to offer gene analyses for a wide range of medical, research and pharmaceutical applications. The company provides DNA and RNA sequencing of humans, animals, plants, and microorganisms, and also offers genetic analysis to researchers and pharmaceutical companies for clinical trials and medical innovations, helping doctors and patients find the genetic causes of rare diseases.

Contact Information

Website
cegat.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Paul-Ehrlich-Strasse 23
  • 72076 Tubingen
  • Germany
+49 07071 0000000
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Paul-Ehrlich-Strasse 23
  • 72076 Tubingen
  • Germany
+49 07071 0000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CeGaT Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CeGaT‘s full profile, request access.

Request a free trial

CeGaT Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of diagnostic biotechnology services intended to offer gene analyses for a wide range of medical, research and
Biotechnology
Tubingen, Germany
210 As of 2020
000000000

000000

consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillu
0000000000000
Salt Lake City, UT
0000 As of 0000
00000
00000000 00000

000 00

ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Dui
0000000000000
Dublin, Ireland
00 As of 0000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CeGaT Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Myriad Genetics Corporation Salt Lake City, UT 0000 00000 00000000 00000
ERS Genomics Corporate Backed or Acquired Dublin, Ireland 00 000000&0
OncoDNA Venture Capital-Backed Gosselies, Belgium 000 000.00 00000000000 000.00
Ambry Genetics Private Equity-Backed Aliso Viejo, CA 000 000000&0
Intellia Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000 - 000 00000
You’re viewing 5 of 40 competitors. Get the full list »

CeGaT Executive Team (3)

Name Title Board Seat
Dirk Biskup Ph.D Co-Founder and Managing Director
Saskia Biskup Ph.D Co-Founder & Managing Director
You’re viewing 2 of 3 executive team members. Get the full list »

CeGaT Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CeGaT Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CeGaT‘s full profile, request access.

Request a free trial

CeGaT FAQs

  • When was CeGaT founded?

    CeGaT was founded in 2009.

  • Who is the founder of CeGaT?

    Dirk Biskup Ph.D and Saskia Biskup Ph.D are the founders of CeGaT.

  • Where is CeGaT headquartered?

    CeGaT is headquartered in Tubingen, Germany.

  • What is the size of CeGaT?

    CeGaT has 210 total employees.

  • What industry is CeGaT in?

    CeGaT’s primary industry is Biotechnology.

  • Is CeGaT a private or public company?

    CeGaT is a Private company.

  • What is CeGaT’s current revenue?

    The current revenue for CeGaT is 00000.

  • Who are CeGaT’s investors?

    B. Braun has invested in CeGaT.

  • Who are CeGaT’s competitors?

    Myriad Genetics, ERS Genomics, OncoDNA, Ambry Genetics, and Intellia Therapeutics are some of the 40 competitors of CeGaT.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »